The World Anti-Doping Agency (WADA) is an organisation founded by the International Olympic Committee in 1999 to monitor, encourage and harmonise the fight against doping in sport.
WADA, which is based in Canada, is compliant with six international standards. These standards are the Prohibited List, Testing and Investigation, Laboratories, Therapeutic Use Exemptions (TUEs), Protection of Privacy and the Code of Compliance by the Signatories.
In this article, the focus is on the second code. The procedure to be used by all anti-doping organisations (ADOs) across the world for collecting biological samples for testing is outlined in the International Standard for Testing and Investigations, published by WADA in 2017. WADA is funded by governments across the world and by the Olympic Movement. All popular sporting organisations are signatories to the WADA code and are, as such, subject to the required compliance and sanctions.
The ADOs present in the Caribbean are the Caribbean Regional Anti-Doping Organisation (CARADO), which provides anti-doping services for 17 Caribbean countries and the Jamaica Anti-Doping Commission (JADCO), which provides services to Jamaica.
Athletes competing in any sport, for which the sporting organisation is a signatory to the WADA code, are subject to drug testing. Organisations such as the International Football Federation, International Cricket Council, World Athletics and even the World Chess Federation are signatories to the code.
Athletes competing at the national or international level may be added to a national/international registered testing pool. The athlete is notified that they have been selected to be a part of the testing pool. They are then provided with a list of what they are required to do. Athletes in the registered testing pool are required to submit electronic calendars indicating where they will be available for random testing during a one-hour period of each day. Overnight accommodation, regular activities (training, school or work) and competition times are also be submitted. Submission of whereabouts must be done before the start of each quarter of the year (January 1, April 1, July 1 and October 1). Submission is done on the Anti-Doping Administration Management System (ADAMS) website or mobile application. It is very similar to the Google calendar on mobile phones.
Notification
There are two types of tests, in-competition and out-of-competition testing. In-competition tests may be random, such as the selection of whichever athlete places fourth or first, or it may be a targeted test. Out-of-competition tests are usually more random, the athlete does not know when or where they will be tested. Once selected for testing, an athlete is notified by a chaperone or a Doping Control Officer (DCO) and they are read and are allowed to read their rights and responsibilities. At this point, the doping control personnel ensures the athlete has a clear understanding of the procedure and informs the athlete of the type of sample needed. Samples may be urine, blood or both. The athlete is also informed that they may not over-hydrate as that may produce an unsuitable sample. The athlete must sign to confirm they understand that they have been notified and must remain in direct observation until the sample is provided.
Sample Collection
The athlete is taken to the doping control station, which is usually a designated room during competitions or at the athlete’s selected location based on submission on ADAMS. The DCO oversees the sample collection process and collects personal information from the athlete. The athlete is also allowed to declare blood transfusions, medications or supplements taken recently. The athlete is asked to provide a minimum of 90mls of urine under direct observation of the DCO or chaperone. Once collected, the sample’s concentration is tested to confirm it is a suitable sample. If the sample is too diluted or if the quantity is less than 90mls, another sample must be collected until the appropriate quantity is achieved. The sample is packaged into two bottles, A and B, which cannot be reopened without the designated machines. The athlete must sign and be given a copy of all documentations. The document is sent with the sample to a WADA accredited laboratory for testing. The athlete is notified if there is an adverse finding.
Blood sample is collected, packaged and processed in much the same way but a Blood Collection Officer (phlebotomist trained in athlete sample collection) is responsible for the venipuncture. The athlete must be seated for at least ten minutes before sample collection. Depending on the type of blood test, such as the Athlete Biological Passport, additional information may be required (use of hypoxic masks, high altitude training, blood transfusions etc). The samples are packaged in tamper-proof tubes and kept in a refrigerated box until they arrive at the lab for testing.
All samples are assigned a unique number and the documents submitted to the lab will only have those numbers to identify the sample. No identifiable athlete’s personal information is given to any laboratory. The athlete will be contacted only if there is an adverse analytical finding.
Dr Facey is attached can be reached at aldeam.facey@uwimona.edu.jm